Evaluation of Nε-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy

被引：0

作者：

X. Zhang

Y. Lai

D. R. McCance

K. Uchida

D. M. McDonald

T. A. Gardiner

A. W. Stitt

T. M. Curtis

机构：

[1] The Royal Victoria Hospital,Centre for Vision Sciences, School of Biomedical Sciences, The Queen’s University of Belfast, Institute of Clinical Sciences

[2] Royal Victoria Hospital,Regional Centre for Endocrinology and Diabetes

[3] Nagoya University,Department of Food and Biodynamics

来源：

Diabetologia | 2008年 / 51卷

关键词：

Acrolein; Advanced lipoxidation end-products; Diabetic retinopathy; FDP-lysine; Haemoglobin; Oxidative stress; Serum;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 19 条

[1] Evaluation of Nε-(3-formyl-3,4-dehydropiperidino)lysine as a novel biomarker for the severity of diabetic retinopathy
Zhang, X.
Lai, Y.
McCance, D. R.
Uchida, K.
McDonald, D. M.
Gardiner, T. A.
Stitt, A. W.
Curtis, T. M.
DIABETOLOGIA, 2008, 51 (09) : 1723 - 1730
[2] Evidence supporting a role for Nε-(3-formyl-3,4-dehydropiperidino)lysine accumulation in Muller glia dysfunction and death in diabetic retinopathy
Yong, Phaik Har
Zong, Hongliang
Medina, Reinhold J.
Limb, G. Astrid
Uchida, Koji
Stitt, Alan W.
Curtis, Tim M.
MOLECULAR VISION, 2010, 16 (270): : 2524 - 2538
[3] Association of serum Nε-Carboxy methyl lysine with severity of diabetic retinopathy
Mishra, Nibha
Saxena, Sandeep
Shukla, Rajendra K.
Singh, Vinita
Meyer, Carsten H.
Kruzliak, Peter
Khanna, Vinay K.
JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (03) : 511 - 517
[4] Imino [4+4] cycloaddition products as exclusive and biologically relevant acrolein-amine conjugates are intermediates of 3-formyl-3,4-dehydropiperidine(FDP), an acrolein biomarker
Takamatsu, Masayuki
Fukase, Koichi
Kurbangalieva, Almira
Tanaka, Katsunori
BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (22) : 6380 - 6386
[5] Glycation product carboxyethyl-lysine, a potential biomarker for severity and progression of diabetic retinopathy (DR) in patients with chronic type 1 diabetes mellitus (TIDM)
Sun, Jennifer K.
Keenan, Hillary A.
Cavallerano, Jerry D.
Strauch, Christopher
Sell, David R.
Monnier, Vincent M.
Aiello, Lloyd P.
King, George L.
DIABETES, 2008, 57 : A236 - A236
[6] Evaluation of novel adipokines (omentin-1, apelin and chemerin) as potential biomarkers of presence and severity of diabetic retinopathy in type 2 diabetes patients
Yasir, M.
Senthilkumar, G. P.
Ramesh-Babu, K.
Vadivelan, M.
DIABETOLOGIA, 2019, 62 : S505 - S505
[7] CTRP3 is a novel biomarker for diabetic retinopathy and inhibits HGHL-induced VCAM-1 expression in an AMPK-dependent manner
Yan, Zheyi
Zhao, Jianli
Gan, Lu
Zhang, Yanqing
Guo, Rui
Cao, Xiaoming
Lau, Wayne Bond
Ma, Xin
Wang, Yajing
PLOS ONE, 2017, 12 (06):
[8] Synthesis and evaluation against Leishmania amazonensis of novel pyrazolo[3,4-d]pyridazinone-N-acylhydrazone-(bi)thiophene hybrids
Jacomini, Andrey P.
Silva, Michael J. V.
Silva, Rai G. M.
Goncalves, Davana S.
Volpato, Helito
Basso, Ernani A.
Paula, Favero R.
Nakamura, Celso V.
Sarragiotto, Maria Helena
Rosa, Fernanda A.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 124 : 340 - 349
[9] Michael Cyclization of Polarized Systems: Synthesis and in vitro Anti-Diabetic Evaluation of Some Novel Pyrimidine, Pyridine, Pyrazole and Pyrazolo[3,4-b] pyridine Derivatives
Soylem, Essam A.
Assy, Mohammed G.
Morsi, Ghania M.
CROATICA CHEMICA ACTA, 2017, 90 (03) : 461 - 469
[10] Synthesis and mechanistic evaluation of novel N′-benzylidene-carbohydrazide-1H-pyrazolo[3,4-b]pyridine derivatives as non-anionic antiplatelet agents
Lourenco, Andre L.
Salvador, Raquel R. S.
Silva, Leonardo A.
Saito, Max S.
Mello, Juliana F. R.
Cabral, Lucio M.
Rodrigues, Carlos R.
Vera, Maria A. F.
Muri, Estela M. F.
de Souza, Alessandra M. T.
Craik, Charles S.
Dias, Luiza R. S.
Castro, Helena C.
Sathler, Plinio C.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 135 : 213 - 229

← 1 2 →